Rome, 5 June. (Adnkronos Salute) – Bayer's top desk will be free at the end of 2016: CEO Marijn Dekkers has in fact announced his intention to resign for that period. The German firm noted that "in line with its wishes", Dekkers' contract will be extended by just two years after the initial five-year period has expired. Dekkers, reports 'PharmaTimes', cited family reasons at the origin of the decision.
From Bayer they specify that, to "ensure continuity in key aspects" of the future development of the company, Werner Baumann, current Chief Financial Officer of the pharmaceutical company, will become Chief Strategy and Portfolio Officer with effect from October 1, and his contract will last until at the end of 2017. Johannes Dietsch will also take over his current position at Baumann. Dekkers' appointment in 2010 caused quite a stir, as the Dutchman was the first non-German director to take over the reins of the Leverkusen-based company.
The CEO of Bayer leaves early, off to the waltz of the armchairs
Wednesday 4 June 2014
Of Editorial board
About Pharma and Medical De
